For the past 40 years, CSafe Global has supported life-science companies in keeping temperatures at appropriate levels, delivering temperature protection for their vital life-enhancing products as they ship to patients around the world.

Today, CSafe announced that it is expanding its passive packaging portfolio with the launch of the new AcuTemp Plus Series to address the cold chain needs of commercial pharma, clinical trials, and cell and gene therapies. With “high-performing” Vacuum Insulated Panels (VIP) and single temperature phase change material (PCM), the company says that this enhanced series is “optimally designed for performance, simplicity and efficiency”.

“The AcuTemp Plus Series has been developed with our customers in mind, offering them the level of performance and quality they expect, while delivering the peace of mind they deserve,” stated Patrick Schafer, CEO of CSafe Global. “The new AcuTemp Plus Series represents a new era in reusable VIP passive packaging, providing an end-to-end cold chain solution with an industry-leading level of temperature performance.”

CSafe developed its new packaging solution through a combination of proprietary VIP and enhanced PCM technology. Test results of the new product range have reportedly been impressive, with temperature performances allegedly outlasting other market available solutions.

All AcuTemp Plus Series solutions are designed for simplicity with minimal solution components. Additionally, the AcuTemp Plus Series has been designed for efficiency, leveraging a fully managed end-to-end retest and reuse program - REPAQ®.  With this industry-first reuse program, CSafe argues that its product is uniquely dedicated to thermally re-qualifying VIP panels on every parcel shipper returned, to guarantee “like new” performance of the reusable packaging solution.